We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid (Rituximab2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00525616
Recruitment Status : Completed
First Posted : September 6, 2007
Last Update Posted : September 8, 2014
Information provided by (Responsible Party):
University Hospital, Rouen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2013
  Study Completion Date : December 2013